Biozoom (BIZM) Positioned To Leverage Multiple Lucrative Healthcare Trends
GENEVE, SWITZERLAND -- (Marketwired) -- 06/21/13 -- Biozoom (OTCQB -
BIZM), With an aging population in North America and elsewhere,
healthcare-related devices represent a massive opportunity for
investors. The global home healthcare device industry is expected to
reach $29 billion by 2017, while the do-it-yourself home health
related test market - estimated at $2 billion to $3 billion globally
- is growing by 20% a year.
Developments at Biozoom (OTCQB - BIZM) indicate that the company is
well positioned within this burgeoning trend. Physicians in the Skin
Physiology Department at Charite Berlin Hospital, a renowned teaching
institution in Germany that has produced 11 Nobel winners, recently
tested the company's Biozoom Biofeedback Scanner - and the results
indicate that the small, handheld device could take healthcare,
fitness and multiple consumer markets in entirely new directions.
The non-invasive Biozoom scanner, the size of a TV remote, is a model
of simplicity. With the click of a button and without piercing the
skin, the scanner is able to measuring a variety of health factors,
including tissue perfusion (i.e., blood flow) and the level of
antioxidants, which work to enhance immune defenses, lowering the
risk of cancer and other diseases. A scanner radiates light into the
skin using special LED crystals. The reflected light is absorbed,
relayed and interpreted wirelessly in just a few seconds. The
doctors, who had been using slower, larger and much more expensive
equipment to do the same tests, were impressed with the scanner's
capabilities and results.
The company has taken steps to establish solid protection for its
intellectual property, which has been under development for years,
and solid relationships with some of the best-known names in the
global economy: European telecom giant Vodaphone, which invested in
the concept in the past and remains interested in the technology; and
Carl Zeiss International, a world leader in optical engineering and
the company's partner for the development, engineering and
manufacturing of the device's optical unit.
In the near future, the device may be enhanced in ways that could
expand its uses in healthcare, fitness and the beauty industry. In
fact, if miniaturization continues as planned, it could be embedded
inside smartphones, watches and other consumer products, for instant
feedback on health and fitness. With its ease of use, low price and
usefulness, it may have the potential to be every bit as useful,
addictive and profitable as smartphones.
At fitness facilities, Biozoom scanners could replace the
time-consuming and expensive Vo2Max test for fitness. (The fitness
industry alone generates more than $25 billion in revenues at an
estimated 30,000 locations across the U.S.) At beauty supply stores,
customers could be scanned for free radicals (suspected aging agents)
and skin moisture levels, resulting in recommendations for an
anti-aging creme or a supplement - and which could boost sales at
health-oriented retail outlets and help people get healthier.
One can imagine the Biozoom scanner being used to do screenings in
pharmacies, beauty supply stores, fitness facilities and even big box
food supermarkets. Weight loss programs through companies such as
NutriSystem or Weight Watchers could benefit immediate feedback on
important health biomarkers including cholesterol, blood sugar and
vitamin levels. There's even talk that consumer products companies
such as Unilever, Procter and Gamble, Gillette and Braun could embed
a miniaturized sensor into electric toothbrushes or razors, giving
consumers a quick read on heart disease indicators such as blood
fats, or antioxidant levels and blood sugar. Sports medicine, drug
testing ... the list goes on.
Among all the trends that could impact Biozoom, the change in the
economics of healthcare is the overarching one. A full 70% of all
healthcare spending now goes to treat "lifestyle" diseases. The good
news is that many of these diseases are preventable or reversible -
especially if a device comes along that makes it easier and faster.
The company is forming alliances with industry leaders (according to
one report, IBM expressed interest), there is no other product like
it in the world, it has solid intellectual property that is
protected, and the company's leadership is respected.
In sum, Biozoom is an innovator - and stock - very much worth
Biozoom is an innovative technology development company, specializing
in the commercialization of our advances in mobile spectroscopy. Our
intellectual property portfolio and ongoing research are positioned
to apply Biozoom's technology breakthroughs to a wide range of
markets. Our first consumer product, the Biozoom scanner, gives
people the feedback they need to manage their health, wellness and
fitness on demand. Tested in leading health institutions, our scanner
is the first of its kind-a handheld, transdermal device for measuring
biomarkers, including antioxidant levels, at the click of a button.
Scan results-and customized wellness coaching based on those
biomarkers-are sent instantly to a smartphone or online account. The
scanner will enable leaders in the health and wellness industry to
create new levels of customer loyalty and revenues as a result. For
more information on Biozoom, Inc traded under the stock symbol BIZM,
About BCCS Market Research
BCCS Market Research is the leader in covering market trends driven
by technology and science. BCCS's market research coverage provides
detailed in-depth market forecasts that incorporate the major
economic, scientific, and technological developments in commercial,
pharmaceutical, and high technology companies. BCCS's industry
analysis and market analysis for advanced materials, high-tech
systems and components, nanotechnology and other emerging
technologies is unsurpassed. BCCS's in-depth market analysis has
provided businesses with the insight needed to make intelligent and
strategic business decisions.
BCCS Market Research
Press spacebar to pause and continue. Press esc to stop.